Key Features

• The vendor states the platform ingests thousands of EHR data points and builds a longitudinal, patient-specific baseline rather than relying on one-size-fits-all thresholds.
• According to the vendor, the platform uses a "mixture-of-experts" model architecture with a routing layer that selects which specialized model to trust for a given patient/moment, intended to preserve early sensitivity while reducing false alerts.
• The FDA's own 510(k) clearance letter for the Bayesian Health Sepsis Flagging Device describes it as a continuously monitoring AI/ML software device that analyzes EHR data including patient history, comorbidities, ED chief complaint, labs, vital signs, procedures, medications to aid early detection/risk prediction of sepsis developing within 24 hours.
• Bayesian's peer-reviewed research (Nature Medicine, July 2022), based on 760,000+ patient encounters including 17,500+ with sepsis across five hospitals, found the model's early detection was physician-confirmed in about 1 in 3 flagged cases, at 82% sensitivity and roughly 5.7 hours of lead time before clinical suspicion; a companion study found the combination of model performance and 89% provider adoption was associated with an 18% relative reduction in mortality.
• In a Cleveland Clinic pilot, at Fairview Hospital the software was used on more than 3,330 patients in 2024 and part of 2025, and compared to legacy static-criteria sepsis tools, pilot data showed a tenfold decrease in false alerts, a 46% increase in identified sepsis cases, and a sevenfold rise in cases alerted before antibiotic administration.
• The vendor states the platform's "agentic workflows" surface why a patient is flagged, suggest next steps, coordinate order-set/pathway bundles, and track completion inside the EHR.

Compliance & Security

• HIPAA Compliance: Not disclosed on the vendor's public site (no dedicated security/HIPAA/trust page was found at bayesianhealth.com; as a platform handling PHI in a hospital setting it would be expected to operate under a HIPAA business associate agreement, but no explicit public vendor statement to that effect could be located).
• FDA Status: Cleared (510(k)). FDA clearance letter K250680, dated April 27, 2026 (received) with the clearance issued April 30, 2026, covers "The Bayesian Health Sepsis Flagging Device," under Regulation Number 21 CFR 880.6316 ("Software Device To Aid In The Prediction Or Diagnosis Of Sepsis"), Regulatory Class II, Product Code SAK. Multiple independent health-tech outlets (MedCity News, MedTech Dive, Healthcare Dive, Medical Device Network) reported this as the first FDA clearance for a continuously monitoring AI sepsis tool, and MedTech Dive reported the clearance followed Bayesian's earlier FDA Breakthrough Device Designation. Note that this FDA clearance applies specifically to the sepsis flagging module; the vendor's broader "real-time clinical intelligence platform" and any non-sepsis modules were not confirmed as separately FDA-cleared in public sources.

Integration & Workflow

• Platform: Embedded within existing EHR clinical workflows (in-EHR alerts and order-set/pathway triggers), per the vendor; no separate standalone app or mobile interface was described in public sources reviewed..

Pricing & Access

• Not publicly listed; the vendor's site directs prospective customers to a "Learn More"/contact form rather than publishing pricing or a self-serve trial.

Doxiverse Assessment: Strengths & Limitations

• Strengths: Bayesian Health has a strong independent evidence base for an AI clinical tool in this category: peer-reviewed outcomes research in Nature Medicine, a large multi-hospital pilot dataset reported by Cleveland Clinic's own newsroom (not just vendor marketing), and, distinctively actual FDA 510(k) clearance (Class II, K250680) for its core sepsis-detection function, which multiple independent health-tech outlets and the FDA's own clearance letter confirm; this puts it in a different regulatory category than sepsis tools deployed purely as unregulated "clinical decision support."
• Limitations/Risks: No SOC 2/ISO security certification or explicit HIPAA compliance statement was found publicly, which is a gap buyers evaluating data-security posture should ask about directly (many peer platforms publish this). Pricing is entirely non-public, requiring a sales conversation.

Ideal User Profile

• Best for: Inpatient hospital settings (academic medical centers and community hospitals) with EHR-integrated real-time monitoring capacity and a clinical/quality team focused on sepsis and deterioration detection, based on its confirmed deployments at large multi-hospital academic health systems (Cleveland Clinic, University of Rochester Medicine).
• Not ideal for: Outpatient/ambulatory practices or smaller facilities without inpatient EHR real-time data infrastructure; the tool's public evidence base and FDA clearance are specific to inpatient sepsis detection, not ambulatory or outpatient use cases.

Disclaimer - This profile was compiled from publicly available sources including the vendor's own website, regulatory filings, press coverage, and independent research as of July 2026. Vendor claims are labeled as such and have not been independently audited by Doxiverse. Product features, pricing, certifications, and regulatory status change frequently and may no longer be current; verify all details directly with the vendor before making a purchasing decision. The "Doxiverse Assessment" and "Ideal User Profile" sections reflect Doxiverse's independent editorial analysis based on available sources at the time of writing, not the vendor's endorsement, and the vendor may disagree with this characterization. This profile is provided for informational purposes only and does not constitute a recommendation, endorsement, or professional/legal/clinical advice. Report inaccuracies to contact@doxiverse.com